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I. INTRODUCTION
Discourses on global public health crises, especially as they impact
the less-developed world, focus mostly on the issue of access to life-saving
drugs for needy populations. 2 Also, they implicate the misalignment of
global pharmaceutical research and development (R&D) agenda with the
health needs of the poor.3 Equally attracting significant attention is the role
of intellectual property in driving up the cost of drugs and exacerbating the
drug access freeze to needy populations.4 More often, the conceptual
strings of these discussions are woven around a complex interaction of
themes, including those of globalization, the development narrative, and
strategic changes in international lawmaking, especially in the areas of
intellectual property, international trade, and the correlating supervisory
international institutional and global governance regimes,
1. See Milly Ryan-Harshman, Food Biotechnology: Food Industry, Nutrition and
Public Health, 56 PROC. NUTRITION Soc. 845, 847 (1997).
2. See Michael Zisuh Ngoasong, The Emergence of Global Health Partnerships as
Facilitators of Access to Medication in Africa: A Narrative Policy Analysis, 68 Soc.
SCI. & MED. 949 (2009); NEGOTIATING HEALTH: INTELLECTUAL PROPERTY AND
ACCESS TO MEDICINE (Pedro Roffe, Geoff Tansey & David Vivas-Eugui, eds., 2005);
HOLGER P. HESTERMEYER, HUMAN RIGHTS AND THE WTO: THE CASE OF PATENTS AND
ACCESS TO MEDICINES (Oxford University Press 2007); see also Stephen Barnes,
Pharmaceutical Patents and TRIPS: A Comparison of India and South Africa 91 KY.
L.J. 911, 926 (2003); Christopher K. Eppich, Patenting Dilemma: Drugs for Profit
Versus Drugs for Health, 43 SANTA CLARA L. REv. 289, 290 (2002); Frederick M.
Abbott, The Doha Declaration on the TRIPS Agreement and Public Health: Lightening
a Dark Corner at the WTO, 5 J. INT'L ECON. L. 469, 470 (2002); Susan K. Sell, TRIPS-
Plus, Free Trade and Agents and Access to Medicines, 28 LIVERPOOL L. REV. 41
(2007).
3. See Chidi Oguamanam, Patents and Pharmaceutical R&D: Consolidating
Private-Public Partnership Approach to Global Public Health Crises, 13 J. WORLD
INTELL. PROP. 556, 559 (2010); Taiwo A. Oriola, Strong Medicine: Patents, Market,
and Policy Challenges for Managing Neglected Diseases and Affordable Prescription
Drugs, 7 CAN. J. L. & TECH. 57, 60-61 (2009); Ending the R&D Crisis in Public
Health, BRIEFING PAPER No. 22 (Oxfam International), (2008) [hereinafter Briefing
Paper]; Anup Shah, The Pharmaceutical Corporations and Medicinal Research,
GLOBAL ISSUES (Oct. 2, 2010), http://www.globalissues.org/article/52/pharmaceutical-
corporations-and-medical-research.
4. See Thomas K. Mirabile, AIDS, Africa and Access to Medicines, 11 DETROIT
COLL. L. J. INT'L L. 175 (2002); see also Eppich, Sell, Barnes, Abbott, supra note 2,
and Shah, Oguamanam, Oriola, Briefing Paper, supra note 3.
5. See generally SUSAN K. SELL, PRIVATE POWER, PUBLIC LAW AND THE
GLOBALIZATION OF INTELLECTUAL PROPERTY RIGHTS (2003) [hereinafter Private
Power]; PETER DRAHOS & JOHN BRAITHWAITE, INFORMATION FEUDALISM: WHO OWNS
THE KNOWLEDGE ECONOMY? (2002); INTELLECTUAL PROPERTY, TRADE AND
DEVELOPMENT (Daniel Gervais, ed., 2007); Susan K. Sell, The Quest for Global
Governance in Intellectual Property and Public Health: Structural Discursive and
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The emphasis on access to drugs as a panacea for global public health
crises accounts for only one response to a complex situation. It is a
response that focuses mainly on therapeutic intervention, which is often a
crisis-driven initiative. A more strategic response to global public health
crises would be a preventive one. 6  Public health crisis intervention
essentially involves both therapeutic and preventive strategies. These
strategies are not necessarily mutually exclusive. However, in some cases,
a good preventive intervention is more cost-effective, socially and
economically, in part, because it radically reduces the burden and general
cost of therapeutic intervention in the long run.8  For example, on a
cumulative scale, the high rate of infant and maternal mortality in less-
developed countries can be more effectively tackled by strategic investment
in the promotion of sanitary, nutritional and general lifestyle education for
mothers and mothers-to-be. 9 The result of such an approach would be
more enduring than an ad hoc supply of donor-sponsored patented drugs or
dietary supplements at critical stages of pregnancy or postpartum.
Without underrating the subject of access to drugs for needy
populations, this article aims at shifting the focus on the traditional sites of
discussion of global public health crises, especially in the legal literature.
It explores how the relationship between biotechnologies, specifically
agricultural biotechnology, and nutritional health could constitute a tool for
positive public health impact for less-developed countries. As its core
objective, this paper aspires to call attention to a preventive rather than a
therapeutic approach to global health crises, by focusing on public health
aspects of agricultural biotechnology.'o
Institutional, 77 Temple L.R. 363 (2004) [hereinafter Global Governance]; PETER
DRAHOS & JoH'N BRAITHWAITE, GLOBAL BUSINESS REGULATION (2000); CHIDI
OGUAMANAM, INTELLECTUAL PROPERTY IN GLOBAL GOVERNANCE: A DEVELOPMENT
QUESTION (2011).
6. See PUBLIC HEALTH ETHICS: THEORY, POLICY, AND PRACTICE 28-29 (Ronald
Bayer et al., eds., 2007).
7. Id at 29.
8. See generally LAURIE GARRETT, BETRAYAL OF TRUST: THE COLLAPSE OF
GLOBAL PUBLIC HEALTH (2000) (arguing for a concerted internal global strategy for
public health based on preventative measures, including lifestyle changes, monitoring,
equitable access and more objective approaches to understanding of diseases and
appropriative therapeutic interventions).
9. See Jerker Liljestrand, Strategies to Reduce Maternal Mortality Worldwide,
WORLD BANK, HEALTH NUTRITION AND POPULATION, http://info.worldbank.org/etools/
docs/library/48578/Strategies%20to%20reduce%20MMR.doc (last visited Mar. 4,
2012); see also Jerke Liljestrand, Reducing Perinatal and Maternal Mortality in the
World: The Major Challenges, 106 BR. J OBSTET. GYNAECOL. 877 (1999).
10. The link between public health and agricultural biotechnology is approached, for
the most part, within the rubric of broader public policy debates around the reception
and acceptability of biotechnology and associated products, including the debate over
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Mindful of the controversies, reservations and high-stakes debates
surrounding agricultural biotechnology in particular, and the political
economics of global agriculture in general," this paper attempts to rise
above the two extremes of often-uninformed skepticism and uncritical
enthusiasm and sentiments over agricultural biotechnology. This paper
explores how aspects of advances in agricultural biotechnology could be
made accessible, in a sustainable way, to less-developed countries as a tool
to mitigate, in a deliberate and targeted fashion, nutritional lapses that
constitute significant aspects of public health crises in those countries. In
order to mitigate the public health challenges in less-developed countries,
this paper will examine the potential and real obstacles that assail a
selective or targeted deployment of agricultural biotechnology. Finally,
this paper will consider ways around the identified challenges.
II. AGRICULTURAL BIOTECHNOLOGY
The United Nations Convention on Biological Diversity defines
"biotechnology" as "any technological application that uses biological
systems, living organisms, or derivatives thereof, to make or modify
products or processes for specific use."' 2  Literarily, "bio" technology
presupposes the application of technological knowledge, insight and
practices to life forms. In terms of its practical applications, biotechnology
embraces a very wide scope, as "a mdlange of scientific techniques, which
can be applied to alter the genetic composition or genetic structure of an
organism."' 3  It is inherently an interdisciplinary endeavor. 14  When
the appropriate method of public education and information (e.g. through disclosure
and labelling) of genetically engineered products. See Mitchell Berger, Public Health
and Agricultural Biotechnology: A Review of Legal, Ethical and Scientific
Controversies Presented by Genetically Altered Foods (2000) (unpublished MPH
Dissertation, Emory University), available at http://www.dissertation.com/book.php?
method=lSBN&book=1581120931 (last visited Mar. 4, 2012).
11. See generally Berger, supra note 10; see also GENE TRADERS: BIOTECHNOLOGY,
WORLD TRADE, AND THE GLOBALIZATION OF HUNGER (Brian Tokar, ed., 2004);
Carmen G. Gonzalez, Trade Liberalization, Food Security and the Environment: The
Neoliberal Threat to Sustainable Rural Development, 14 TRANSNAT'L L. & CONTEMP.
PROBS. 419 (2004) [hereinafter Trade Liberalization]; ROBERT E. EVENSON, V.
SANTANIELLO, & DAVID ZILBERMAN, ECONOMIC AND SOCIAL ISSUES IN AGRICULTURAL
BIOTECHNOLOGY (2002); Carmen G. Gonzalez, Institutionalizing Inequity: The WTO
Agreement and Agriculture, 27 COLUM. J. ENvTL. L. 433 (2002) [hereinafter
Institutionalizing Inequity]; D. JOHN SHAW, GLOBAL FOOD AND AGRICULTURAL
INSTITUTIONS (2009).
12. United Nations Convention on Biological Diversity, Art. 2, June 5, 1992, 1762
U.N.T.S. 79, available at http://www.cbd.int/convention/text/ (last visited Jan. 31,
2011).
13. John Adeoti & Adetola Adeoti, Biotechnology R & D Partnership for Industrial
Innovation in Nigeria, 25 TECHNOVISION 349, 352 (2005) (citing Rohini Acharya, The
[VOL. 7260
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biotechnological methods are applied to a specific subject area, the latter
becomes an object of the "biotechnology suffix." Agricultural and health
R&D are currently the two most prominent sites for the application of
biotechnology. Specifically, when biotechnology is deployed for the
purpose of R&D in agriculture/food, or health production and delivery, it is
often referred to as health or agricultural biotechnology, respectively. The
concept of agricultural biotechnology includes other applications of
biotechnology in the context of agriculture and food; hence in terms of
specificity, references are made to some open-ended but related fields,
including food, nutrition, environmental, crop or plant biotechnologies.
Thus, the interrelatedness of agriculture, food, nutrition and diet allows for
a fluid conceptualization of the concept of agricultural biotechnology to
accommodate all these associations and more as the case may permit.
A. Genetic Engineering
At the core of biotechnology and, to a large extent, agricultural
biotechnology is the phenomenon of genetic engineering. Genetic
engineering is the practice of using molecular information and other
techniques to deliberately modify or manipulate life forms for various
human needs, especially in health and agriculture, including desirable and
non-desirable or other experimental outcomes.'" It is a critical aspect of
agricultural biotechnology. However, its utility and applications are not
limited to agriculture and food. Genetic engineering is a crucial industrial
tool or model for R&D, especially in pharmaceutical, chemical,
environmental and allied sciences, just to mention a few. In the 21st
century, genetic engineering has radically redefined the face of modem
agricultural, as well as R&D and aspects of service delivery.
B. Competing forms ofAgricultural Practice
The advent of genetic engineering, including industrial use of
recombinant DNA, cell fusion and various new bioprocessing techniques,
as the key features of modem biotechnology in the agricultural arena, has
led to the present, albeit inchoate, attempt at re-categorization of the forms
Impact of New Technologies on Economic Growth (1995) (unpublished PhD
Dissertation, Faculty of Economics and Business Administration, Maastricht
University, Netherlands).
14. See Id. at 349, 352-53 (discussing some of the disciplines implicated in the
exploration of biotechnological activities include genetics, genomics, proteomics,
biology, molecular biotechnology, bioinformatics, food science & technology,
medicine, cell and tissue culture).
15. See Chidi Oguamanam, Agro-Biodiversity and Food Security, MICH. ST. L. REV.
215, 222 (2007).
2612011]
JOURNAL OF FOOD LAW & POLICY
of prevailing agricultural practices. Genetic engineering techniques have
not only broadened the scope of agricultural production, they have also
yielded perhaps the most encompassing definition of biotechnology, "to
include the application of scientific and engineering principles to the
processing of materials by biological agents (e.g. microorganisms) or any
technique that uses living organisms (or parts thereof), to make or modify
products, to improve plants or animals, or to develop microorganisms for
specific uses." 6 Perhaps the encompassing and increasingly central nature
of biotechnology in agriculture contributes to the lack of clarity or
consensus on what now qualifies as conventional farming or agriculture.
Analysts readily make a distinction between "organic" or "biological"
agriculture and "conventional" or "industrial" agriculture. According to a
report by the United Nations University's Institute of Advanced Studies
(UNU-IAS), "'organic or biological agriculture' designates an agricultural
mode of production that does not rely on the use of chemicals, e.g.,
fertilizers and chemical pesticides. It also excludes any genetically
modified organism, and is labour intensive."" On the other hand,
conventional agriculture essentially depicts the mechanization of
agricultural production through emphasis on monocultures, synthetic
inputs, applications of chemical fertilizers, pesticides and various
techniques for the optimization of agricultural production in the short run.
The ample flexibilities and variations in the applications of agricultural
biotechnology place it at the intersection of conventional and industrial
agriculture, especially given regard to the convergence of the two
concepts.19
16. Adeoti & Adeoti, supra note 13, at 352. In its various established forms such as
cell and tissue culture, recombinant DNA/genetic engineering, bioprocessing and
bioinformatics, biotechnology is central to modem agricultural production and health
services delivery, production, as well as R&D in the two sectors.
17. This form of inchoate or arbitrary classification is problematic in many respects.
At best they serve analytical convenience. For example, it is hard to think of an
agricultural practice that is not fundamentally biological in nature.
18. ALBERT SASSON, FOOD AND NUTRITION BIOTECHNOLOGY: ACHIEVEMENTS,
PROSPECTS, AND PERCEPTIONS 24, UNU-IAS Report (2004).
19. Conventional agriculture, simply, is a reference to an intensive approach to
farming, especially at a time when agricultural production was essentially a labor
intensive exercise with little mechanical support. See ANNIE EICHER, ORGANIC
AGRICULTURE: A GLOSSARY OF TERMS FOR FARMERS AND GARDENERS (Feb. 2003),
available at http://watoxics.org/healthy-living/healthy-food/sustainable-agriculture/
Glossary.pdf/at download/file (according to Eicher, the Organic Farming Program
Coordinator for the University of California Cooperative Extension, conventional and
industrialized agriculture have melded in the last 60 years following World War 11.
Consequently, the terms appear to be used interchangeably). See also Horticulture &
Small Farms: Glossary of Terms, UNIVERSITY OF CALIFORNIA, http://ucanr.org/sites/
ceplacerhorticulture/EatLocal/Glossary/ (last visited Mar. 4, 2012).
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Contrary to the impression by the UNU-IAS, it may be inaccurate to
assume that any form of agricultural practice that does not involve genetic
engineering or genetic modification qualifies as "organic" or so-called
biological agriculture, which classification also conveniently fits traditional
agricultural practices in the indigenous and rural communities.2 0  n reality,
entitlement to the often contested "organic" certification in the agricultural
sectors is not necessarily premised on zero tolerance of the presence of
transgenic components. Rather, for the most part, it is now a matter of
marketing and branding. On a more serious, practical and less-delusional
note, organic status is determined more by what constitutes an acceptable
level than the total absence of transgenic material.2 1
Today, genetic engineering is at the core of modem agricultural
biotechnology, which constitutes an important feature of 21st century
technological advancements. All other agricultural practices, including
traditional, non-industrial, labor-intensive or "folk" agricultural practices in
indigenous and local communities, whether they qualify as organic or
biological farming, are often evaluated vis ci vis genetic engineering or
agricultural biotechnology. 22  The latter now constitutes a permanent
comparator in relation to other modes of agricultural production and
practices.23 Thus, it would appear that biotechnology or genetic
engineering and its historical precursor, namely the modification of living
organisms (especially plants and animals) through hybridization and
artificial selection, currently constitute the so-called conventional
agriculture.
In underscoring the evolution and significance of modem
biotechnology in the agricultural arena, it has been observed that:
In the last two hundred years, mechanization, scientific
plant breeding, hybridization, and chemicalization, in
20. See Chidi Oguamanam, Tension on the Farm Fields: The Death of Traditional
Agriculture?, 27 BULL. SCI. TECH. & Soc. 260, 262-63 (2007).
21. See Maria Lee & Robert Burrell, Liability for Escape of GM Seeds: Pursuing the
'Victim'? 65 MOD. L. REV. 517, 518 (2002) (wherein the authors argue that if there is
wide-spread cross-pollination then "GM-free will no longer mean 'no GMOs present';
'organic' will not mean GM-free"); see also Commission Regulation 1804/99, art. 23,
1999 O.J. (L 222/1) (EC) (supplementing Regulation on Organic Production of
Agricultural Products, 2092/91, 1991 that provides for a maximum threshold of
inadvertent contamination without loss of certified organic status); Oguamanam, supra
note 20, at 269 (where the author observes that "[r]ealistically, many organic farmers
are concerned with determining what amount of transgenic material would be
unacceptable for organic certification. Indeed, for consumers, the "organic label" poses
a semiotic quandary rather than being a safety or quality assurance alternative to
transgenic food products").
22. See Oguamanam, supra note 15; see also Oguamanam, supra note 20.
23. Id.
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terms of the use of pesticides, herbicides, and fertilizers,
have become the key features of agricultural practices in
the industrialized world. 'The discovery of recombinant
DNA in the early 1970s rapidly opened new frontiers' in
the agricultural revolution. Essentially, they involve
applications of molecular genetics or biological processes
in agriculture through the selection of natural strains (gene
splicing) associated with desirable traits and other
molecular and scientific devices for the manipulation of
plant and animal life forms. 24
Accordingly, the art and science of "gene splicing" or genetic
manipulation is a crucial feature of agricultural biotechnology, a subset of
biotechnology steeped in diverse techniques for manipulating genetic
material of living organisms and for exploring and exploiting the complex
chemistry of biological systems for food production and other agro-
industrial ends."25 In terms of its significance, "[t]he advent of agricultural
biotechnology (as an offshoot of biotechnology) shifts agriculture from
land-based farming and opens it up to transdisciplinary convergences in
therapeutics, pharmaceuticals, chemicals and marketing in complex
industrial and political economics of globalization," 26 transforming it from
a mode of life to a mode of production.27
The manipulation of plant and animal genes for food production
opens the practice of agriculture to possibilities that transcend addressing
global hunger. In other ways, this approach to agricultural production
provides a concrete basis for reflective critique or understanding of the
limitations of organic/biological and other non-conventional agricultural
practices. Nonetheless, the advent of agricultural biotechnology and its
modus operandi are as controversial as its real, perceived or potential
benefits. Resistance or opposition to agricultural biotechnology is more
often premised on the disputation over most of the benefits claimed by its
proponents.28 In some ways, the ongoing debate between proponents and
opponents of agricultural biotechnology assists to unravel the gaps in
competing models of agricultural endeavor. As well, such conversation
24. Oguamanam, supra note 15, at 221-22 (footnotes omitted).
25. Id at 222.
26. Id.
27. See SHELDON KRIMSKY & ROGER P. WRUBEL, AGRICULTURAL BIOTECHNOLOGY
AND THE ENVIRONMENT: SCIENCE, POLICY AND SOCIAL ISSUES 213 (1996).
28. See Jeffrey Burkhardt, Agricultural Biotechnology and Future Benefits
Argument, 14 J. AGRIC. & ENVTL. ETHICS 135 (2001) for a general review of the
philosophical basis/justification for agricultural biotechnology and an exploration the
future benefit analysis (FBA) in regard to prevailing objections to genetically modified
organisms.
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provides an opportunity for the exploration of the potential for
complementary engagement and application of the benefits of agricultural
biotechnologies alongside other models of agricultural production for
optimal ends. Without being exhaustive, the following few examples
illustrate the polarizing claims, counterclaims and resistances that
undergird the tension between agricultural biotechnology, especially
genetic engineering, and other modes of agricultural production.
III. AGRO-BIOTECH VS. OTHERS: CLAIMS AND COUNTERCLAIMS
A. Sustainability, Cost, Efficiency and Environmental Arguments
Promoters of organic or non-conventional agriculture are quick to
claim that, in comparison to conventional or industrial agriculture
(including agricultural biotechnology), their approach is more natural, more
environmentally friendly and more sustainable in the long run.29 For a
number of reasons, this would seem self-evident. Organic or biological
agriculture - hardly precise terms - is labor-intensive, diversity-sensitive,
and mostly subsistent, involving the use of little or no chemicals, and
mainly engages in natural selection, shifting cultivation and other
environment-regarding practices. In contrast, conventional agricultural
practices, especially agricultural biotechnology, are industry-driven; they
involve full-scale, energy-intensive industrial monocultural production and
direct manipulation of genetic compositions of life forms.
When all of these claims are unpacked, they do not seem as settled as
they are presented. For instance, claims to sustainability are as contested as
those for environmental friendliness made in favor of organic or biological
agriculture. Interestingly, the same claims are also made in support of
agricultural biotechnology. Organic agriculture is said to amass too much
pressure on agricultural lands. 30 The amount of agricultural land required
for sustainable organic farming far exceeds land use for conventional
agriculture. 31 Also, organic or forms of non-conventional agriculture, do
not adequately or readily adjust to radical changes in the natural
29. This is often in contrast to the process of gene splicing or genetic engineering,
which involves direct artificial manipulation or tinkering with the genetic compositions
of living organisms. Ironically, biotechnology is also represented as hardly at odds with
the natural process and as indeed based on "nature's own methods." For perspectives
on the contested ideology of nature and natural process in an agricultural context, see
KRIMSKY & WRUBEL, supra note 27, at 227; see also Oguamanam, supra note 15, at
222.
30. See Milly Ryan-Harshman, Food Biotechnology: Food Industry, Nutrition and
Public Health, 56 PROC. NUTRITION Soc. 845, 846 (1997).
3 1. Id.
265201l]1
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environment such as drought, soil erosion, severe changes in weather
patterns, etc.
Agricultural biotechnology is associated with the potential to cut back
on the amount of land required for agricultural production by using
techniques such as no-till farming practices, for example. No-till farming
is "an agriculturally-sustainable method of preventing soil erosion." 32 In
addition, no-till farming prevents various other forms of agriculture-
induced environmental degradation. Also, in some cases agricultural
biotechnology makes it possible to genetically predispose crops to consume
less water or other agricultural nutrients, thus mitigating the pressure on the
natural environment, starting with land, which is historically associated
with agriculture. Cumulatively, these and other related benefits of
agricultural biotechnology provide an empirical basis for the claim by its
proponents that agro-biotechnology is a sustainable agricultural practice.
For example, limiting water consumption for agriculture assumes a
compelling imperative in the light of dire apprehensions over global water
crises, to which many less-developed countries, especially in sub-Sahara
Africa, are vulnerable.33  In drawing attention to the importance of
agricultural biotechnology for global water crises, G.J. Persley remarks that
"[b]ecause land and water for agriculture are diminishing resources, there is
no option but to produce more food and other agricultural commodities
from less arable land and irrigation water. The need for more food has to
be met through higher yields per units of land, water, energy and time." 3 4
Generally, ongoing concerns about global water supply and rapidly-
creeping effects of global climate change require a more creative
agricultural strategy, one now within the purview of agricultural
biotechnology. 3' Despite its advantage in regard to water and land use,
32. Id.
33. Water Crisis, WORLD WATER COUNCIL (2010), http://www.worldwatercouncil.
org/index.php?id=25 (last visited Mar. 1, 2012) ("water withdrawals for irrigation
represent 66 % of the total withdrawals and up to 90 % in arid regions"). Globally, per
capita water use reflects the dichotomous difference in lifestyle between rich and poor
societies. Consequently, given the spatial, geographical, ecological, even temporal
variations in the availability of water, there is an increasing scarcity of water for human
needs, especially in agricultural production in Sub-Saharan Africa and other vulnerable
regions of the globe. This state of affairs is a recipe for food insecurity. See generally
Igor A. Shiklomanov, World Water Resources and their Use, UNESCO (1999),
http://webworld.unesco.org/water/ihp/db/shiklomanov/index.shtml (for databases
providing information on world water usage).
34. See G.J. Persley, Biotechnology and the Poor: Promethean Science, in
BIOTECHNOLOGY AND THE POOR 3, 3 (G.J Persley & M.M. Lantin eds., 2000).
35. For example, agricultural biotechnology is a tool of intervention in crop
production systems, including the development of genetically engineered crops capable
of adapting and better responding to change in climate. See Travis Lybbert and Daniel
Summer, Agricultural Technologies for Climate Change Mitigation and Adaptation in
266 [VOL. 7
TOWARD A CONSTRUCTIVE ENGAGEMENT
there are reservations about the negative environmental ramifications of
agricultural biotechnology, especially those that stem from its direct or so-
called non-natural manipulation of genetic compositions of plants and
animals. The result of these interventions is the introduction, by raw
ingenuity of human intervention, of what analysts call strangers or non-
naturally occurring entities to the ecosystem. The presence of these
genetically modified organisms (GMOs) is associated with environmental
and ecological distortions, the full impact of which are hard to measure
both in the long and short runs.
Notwithstanding attempts to downplay problems around GMOs from
health, environmental, safety, cultural, philosophical and other
perspectives, these anxieties have yet to abate.38 Opposition to GMOs and
the processes of their production has continued to galvanize
environmentalist rhetoric that appears to have defined agricultural
biotechnology in the court of public opinion. The environmentalist
critiques of GMOs seem to overshadow (or at least compete with) other
more tenable arguments in support of the potential or real contributions of
agricultural biotechnology to sustainable agriculture. The short point is
that as between organic or non-conventional agricultural practices and
agricultural biotechnology, especially the practice of genetic engineering,
claims to the environmental friendliness and sustainability of their
endeavors are contested and do not lend themselves to easy resolution.
Developing Countries: Policy Options for Technological Diffusion, ICTSD Issue Brief
#6 (May 2010), available at http://www.scribd.com/doc/45728070/Agricultural-
Technologies-for-Climate-Change-Mitigation-and-Adaptation-in-Developing-
countries. See also Green Biotechnology and Climate Change, THE EUROPEAN
ASSOCIATION FOR BIOINDUSTRIES, (June 2009), http://www.europabio.org/positions/
GBE/PP 090619 ClimateChange.pdf.
36. See Oguamanam, supra note 28, at 222 and accompanying text.
37. Analysts readily point to a 1999 research finding suggesting that pollen from
genetically modified Bt corn was harmful to the larvae of monarch butterflies. See
John E Losey, Linda S. Rayor & Maureen E. Carter, Transgenic Pollen Harms
Monarch Larvae, 399 NATURE 214 (1999). This and similar research has been disputed
in some quarters, including at the USDA, a situation that further fosters the controversy
over agricultural biotechnology. Like most claims over agricultural biotechnology,
research on the effect or impact BT com pollen on monarch butterfly remains
inconclusive and is hardly resolved with any clarity. For general overview of the state
of literature on Bt corn and the monarch butterfly, see Richard L. Hellmich, Monarch
Butterflies and Bt Corn, AGRICULTURAL BIOTECHNOLOGY (March 8, 2008),
http://agribiotech.info/details/Hellmich-Monarch%20Mar%208%20-%2003.pdf.
38. For a general articulation of arguments against agricultural biotechnology from
diverse perspectives, see Miguel A. Altieri, The Case Against Agricultural
Biotechnology, CORPWATCH (June 10, 2003), http://www.corpwatch.org/article.php?id
=7030.
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B. Boost in Global Food Production and Panacea to Global Hunger
The second aspect of these contested claims is one that appears
obvious on its face: agricultural biotechnology boosts global food
production and constitutes a panacea to global food insecurity. 39 Increased
food production at a mind-boggling industrial scale is facilitated by diverse
techniques of agricultural biotechnology. This would appear to be a
palpable contention. However, whether that translates into any significant
impact on the reduction of hunger and promotion of food security is
another matter entirely. Some analysts do not find a corollary between
increased food production in the present era of agricultural biotechnology
and any significant reduction of hunger, especially among the global
population in dire need. 40 Also, there is no compelling correlation between
advances in agricultural biotechnology and food security. More critical
policy introspection around agricultural biotechnology suggests that the
technological approach is not indispensable to tackling global hunger. Put
differently, without agricultural biotechnology, the world is capable of
feeding itself.41 For many, global hunger is less a consequence of food
production than of food distribution and the global political economics of
agriculture.42
The dubious impact of agricultural biotechnology, or industrial
agriculture in general, on both the eradication of hunger and food
39. See Biotechnology in Food and Agriculture: FAO Statement on Biotechnology,
FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS (March 2000),
http://www.fao.org/biotech/fao-statement-on-biotechnology/en/.
40. See Carmen G. Gonzalez, Markets, Monocultures and Malnutrition: Agricultural
Trade Policy Through an Environmental Justice Lens, 14 MICH. ST. J. INT'L L. 345,
351, 359-60 (2006); see also Gonzalez, Institutionalizing Inequity, supra note 11.
41. See Margareta Wandel, Genetically Modified Foods in Norway: A Consumer
Perspective in BIOTECHNOLOGY UNGLUED: SCIENCE, SOCIETY AND SOCIAL COHESION
70 (Michael D. Mehta, ed., 2005) (contending that in Norway and other Scandinavian
countries where a more deliberative and critical policy approach is the norm for
evaluating agricultural biotechnology, policy makers recognize that agricultural
biotechnology is not sine qua non for addressing hunger and food supply.; see
generally Altieri, supra note 37.
42. See generally Gonzalez, Trade Liberalization; Brian Tokar, The World Bank,
Biotechnology and the 'Next Green Revolution' in GENE TRADERS: BIOTECHNOLOGY,
WORLD TRADE, AND THE GLOBALIZATION OF HUNGER (Brian Tokar, ed., 2004);
Devinder Sharma, The Great Trade Robbery: World Hunger and the Myths of
Industrial Agriculture in Tokar, supra note I1; GORDON CONWAY, THE DOUBLY GREEN
REVOLUTION: FOOD FOR ALL IN THE TWENTY-FIRST CENTURY (1997); FRANK ELLIS,
AGRICULTURAL POLICIES IN DEVELOPING COUNTRIES (1992); LIZ YOUNG, WORLD
HUNGER (1997); and Food Security Statistics, FOOD AND AGRIGULTRUAL
ORGANIZATION OF THE UNITED NATIONS (2008), http://www.fao.org/economic/ess/
food-security-statistics/en/.
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insecurity, is tied to the global political economics of agriculture.4 3 This
phenomenon has been dealt with elsewhere and is outside the scope of this
paper. The global political economics of agriculture are driven in part by
the international historical division of labor.45 In that matrix, less-
developed countries and centers of agricultural biodiversity serve as
producers of raw materials and feeders of global commodity markets under
inequitable bargains.46 Coupled with the globalizations in legal and
regulatory frameworks of the new international trade and intellectual
property order, there is unprecedented tightening of corporate proprietary
control of new technological innovations in agriculture and allied sectors.47
Consequently, access to the benefits of increased food production in the
wake of advances in agricultural biotechnology remains a challenge.48
Rather, there is an exacerbation in unidirectional transfer of resources and
knowledge from less-developed countries to the Western agro-industrial
complexes.4 9
C. Food Security and Food Safety
Even if agricultural biotechnology results in increased food supply to
feed the world's poor, such does not necessarily translate into an
43. See Young, supra note 42, at 150; Gonzalez, Trade Liberalization, supra note
11, at 422; Conway, supra note 42, at 288-89.
44. See generally Gonzalez, supra note 40 and Gonzalez, Institutionalizing Inequity,
supra note 11.
45. Id.
46. Gonzalez, Trade Liberalization, supra note 11, at 433-34.
47. See generally Altieri, supra note 38; Carmen Gonzalez, Genetically Modified
Organisms and Justice: The International Environmental Justice Implications of
Biotechnology, 19 GEO. INT'L ENVTL. L. REV. 580 (2007); see also Keith Aoki &
Kennedy Luvai, Reclaiming 'Common Heritage' Treatment in International Plant
Genetic Resourc'es Regime Complex, MICH. ST. L. REV. 35 (2007).
48. See AGRICULTURAL BIOTECHNOLOGY AND THE POOR (2000), (J.G. Persley &
M.M. Lantin eds.).
49. According to Altieri, supra note 38, "Biotechnology is a technology under
corporate control, protected by patents and IPR, and contrary to famers' millenary
traditions of saving and exchanging seeds." There is a relationship of dependence
between biotechnology and traditional agricultural, medicinal, genetic resources,
practices and associated knowledge systems in indigenous and local communities and
centers of biological diversity. As a consequence of this epistemic dynamic,
biotechnology is a site for appropriation of local knowledge systems through the
incorporation or use of insights from local knowledge custodians in biotechnology
R&D. While the latter is easily a subject of intellectual property protection, the extent
to which intellectual property accommodates local knowledge is open to politico-legal
negotiations. This state of affairs is at the basis of discourses around the concept of
biopiracy. See generally, IKECHI MGBEOJI, GLOBAL BIOPIRACY: PATENTS, PLANTS AND
INDIGENOUS KNOWLEDGE (2006); VANDANA SHIVA, MONOCULTURES OF THE MIND:
PERSPECTIVES ON BIODIVERSITY AND BIOTECHNOLOGY (1993).
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improvement in food security. The misalignment of agricultural
biotechnology with food security is rooted in complex dynamics. A few
factors assist to illustrate this point. Most of the technologies, including
agricultural biotechnologies, are concentrated in the rich industrialized
countries of the world.50 These countries have championed recent strategic
changes that have resulted in the tightening of intellectual property law in a
manner that guarantees them firm control of innovations in agricultural and
other technological sectors.5 ' In addition, continued convergences in
agricultural biotechnology, chemical, pharmaceutical and allied industries
and the relaxation of anti-trust laws help to consolidate monopolistic
tendencies in these sectors.52 A combination of these and other factors
invigorated by globalization's neo-liberal economic and trade liberalization
policies demonstrate that advances in agricultural biotechnology may not
be a panacea for food insecurity, especially in less-developed countries.
Food security is a concept with multiple perspectives. Overall,
virtually all perspectives on food security denote physical and economic
accessibility by all peoples at all times to adequate, safe, nutritionally
suitable, and culturally and personally acceptable food in manner that is
50. This trend is not necessarily sustainable as it has potential for transformation.
For example, the two interrelated and paradigmatic technologies of the last and present
centuries, namely information and communications technology and biotechnology, are
critical in the ongoing exponential developmental progress and transitions in the three
key less-developed countries of Brazil, India and China (analysts have joined Russia to
the three under the so-called BRIC bloc of countries). These countries have the
potential to rival the United States, Canada and Argentina, now the current global
leaders in agricultural biotechnology. For perspectives on the BRICs, which recently
admitted South Africa into their exclusive group, see Dominic Wilson and Roopa
Purushothaman, Dreaming With BRICs: The Path to 2050, Global Economics Paper
No. 99, GOLDMAN SACHS (October 1, 2003), http://antonioguilherme.web.br.com/
artigos/Brics.pdf.
51. The TRIPS Agreement is the symbolic depiction of new changes in intellectual
property. In a way, TRIPS is a global imposition of the U.S.'s all-inclusive and
permissive intellectual property regime into the realm of life forms, specifically
incorporating innovations around genetic resources. In addition, the United States's
continued negotiation of bilateral trade agreements after TRIPS and its support for the
WIPO Patent Agenda gradually prods the international intellectual property order onto
a TRIP-plus regime. See SUSULE F. MUSUNGU & GRAHAM DUTFIELD, MULTILATERAL
AGREEMENTS IN A TRIPS-PLUS WORLD: THE WORLD INTELLECTUAL PROPERTY
ORGANIZATION (2003), (exploring how recent intellectual property reforms at the
WIPO, especially the patent and digital agenda promote and co-opt less-developed
countries into standard of intellectual property protection that transcend those of the
TRIPS Agreement); see also Jean-Frid6ric Morin, Multilateralising the TRIPS-Plus
Agreement: Is the US Strategy a Failure?, 12 J. WORLD INTELL. PROP. 175 (2009).
52. See Susan K. Sell, supra note 5, at 369-70.
53. See FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS, TRADE
REFORMS AND FOOD SECURITY: CONCEPTUALIZING THE LINKAGES 25-26 (2003).
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sensitive to their human dignity and for their overall active and healthy
lifestyle. 54 It follows that food security, food safety, nutrition, and public
health have a symbiotic relationship. Forms of agricultural production,
including so-called conventional and non-conventional agriculture, are
practices at the critical intersection of food security and food safety. We
shall explore that intersection in the next section.
From the above overview of food security, it is possible that
agricultural biotechnology has real and practical potential to advance or
undermine food security. In regard to advancing food security, agricultural
biotechnology may not, however, be a magic bullet. Its role could be
complemented by other modes of agricultural production and practices in
order to factor in the cultural and human dignity aspects of food security.
As for the second potential, there are many ways in which agricultural
biotechnology could undermine food security. For instance, the industrial
and commercial focus of agricultural biotechnology accounts for the
concentration of research, and innovative and developmental endeavors on
a few monocrops." Because agricultural biotechnology is industrially and
commercially driven, it targets crops and plants on the basis of their
commercial viability. 56 That priority is hardly the driving factor in
indigenous and rural communities where agriculture is first a cultural
process and a factor of cultural and ecological diversities of people and
their environment.
Consequently, in some ways, agricultural biotechnology appears to be
antithetical to agro-biodiversity. The idea of agro-biodiversity refers, for
the most part, to diverse ways in which "farmers use the natural diversity of
the environment for production, including not only their choice of crops but
also their management of land, water, and biota as a whole."57 Because
agricultural and food production are culturally located and culturally driven
practices, they correlate with diversities in the ecological features of
peoples and civilizations. In that way agricultural biodiversity guarantees
54. See Oguamanam, supra note 15, at 230; Ryan-Harshman, supra note 30, at 845.
55. See Persley & Lantin, supra note 48; see also Altieri, supra note 38; see
generally Shiva, supra note 49.
56. See Jay P. Kesan, Intellectual Property Protection and Agricultural
Biotechnology: A Multi Disciplinary Perspective, 44 AM. BEHAv. Scl. 464, 465-66
(2000); see generally Bongo Adi, Intellectual Property in Biotechnology and the Fate
of Poor Farmers' Agriculture, 9 J. WORLD INTELL. PROP. 91 (2006); Oguamanam,
supra note 20.
57. Oguamanam, supra note 15, at 220 (quoting Harold Brookfield & Christine
Padoch, Appreciating Diversity: A Look at the Dynamism and Diversity of Indigenous
Farming Practices, 36 ENVIRONMENT 6, 9 1994).
58. See Assya Pascalev, You Are What You Eat: Genetically Modified Foods,
Integrity and Society 16 J. AGRIC. ENvTL. ETHICS 583 (2003); see also HARRIET V.
KUHNLEIN & NANCY J. TURNER, TRADITIONAL PLANT FOODS OF CANADAIAN
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aspects of food security, especially in regard to access to
culturally/personally acceptable foods, which are reflective of the human
dignities of peoples.
In contrast, biotechnology's tendency to promote monocultures short-
changes a crucial aspect of food security for a critical segment of the
population that relies on the diversity in traditional landraces and animal
resources. Also, the political economics of agriculture tightens proprietary
control of the end products of innovations in agricultural biotechnology and
creates a culture of dependence on technologically endowed countries by
many in the less-developed world. Physical access to agricultural
biotechnology or genetically modified (GM) foods presents considerable
challenges for needy populations 9 akin to those posed by access to
essential drugs. Because of cost, affordability and distribution constraints,
agricultural biotechnology end-products are often delivered to needy
populations in less-developed countries as food aid. 60 Often, like high-end
patented drugs, GM foods are fast becoming part of ad hoc crisis
intervention relief packages. For the recipients in less-developed countries,
this phenomenon detracts from physical accessibility, cultural suitability
and human dignity, which are necessary elements of food security.
The reluctance of some to embrace GM foods and other products of
agricultural biotechnology, in a way, demonstrates the latter's inability to
satisfy the aspect of cultural and human dignity elements of food security.
For many who resist these products due to cultural, philosophical, religious,
environmental and other considerations, the question, however, is not
whether they are physically available, affordable, or nutritionally safe.
Rather, it is whether they are acceptable. 61 The short point here is that the
relationship between agricultural biotechnology and food security unravels
as a more complex analytical morass than what appears obvious at first
glance.
INDIGENOUS PEOPLE: NUTRITION, BOTANY AND USE (1991), available at
http://www.fao.org/wairdocs/other/ai215e/ai215e00.htm.
59. See Conway, supra note 42, at 227; see also Altieri, supra note 38, (arguing that
most rural populations in the tropics live in very challenging environmental condition
and are threatened by global warming while hardly being impacted by modem
agricultural science).
60. See Shaw, supra note 11, at 201 (where the author notes that contrary to the
preference of global food aid agencies such as the UN World Food Program to source
food aid locally to support local economies, donor countries, especially the US, tie food
aid to their interest. The US requires, for example, that donations be sourced from their
surplus stocks and that three-quarters of which be bagged, fortified or processed
products.).
61. See Chidi Oguamanam, Intellectual Property Rights in Plant Genetic Resources:
Farmers' Rights and Food Security in Indigenous and Local Communities, 11 DRAKE
J. AGRIc. L. 273, 301 (2006).
272 [VOL. 7
TOWARD A CONSTRUCTIVE ENGAGEMENT
Finally, in regard to the safety component of the food security
discourse, the role of agricultural biotechnology takes an explosive and
sometimes passionate turn. Perhaps there is as much a case to be made in
favor of agricultural biotechnology's ability to promote food safety as can
be made for its converse impact on food safety. Arguably, most of the
objections to agricultural biotechnology, especially those stemming from
environmental, health and sustainability are aspects of the reservations over
the safety of products of agricultural biotechnology. 62 In short, opposition
to agriculture biotechnology is woven around inter-connected and yet
emerging themes.
In many quarters, the benefits of agricultural biotechnology are
presented as constituting the critical strategy for the advancement of public
health.63 On other fronts, agricultural biotechnology products and
processes are represented as sources of significant threats to public health
and myriad economic and social issues.64 This ironic twist underscores the
contentious nature of policy debate around biotechnology in general and
agricultural biotechnology in particular. Safety concerns over the products
of agricultural biotechnology are more hotly debated in the specific and
interrelated contexts of food, medicine and nutritional health. This is
hardly surprising because, in virtually all civilizations known to mankind,
food has a symbiotic relationship with medicine. 65 Food biotechnology, a
subset of biotechnology and, indeed, agricultural biotechnology, is "the use
of living organisms, or parts of living organisms to create new, or improved
food products."66 The advent of agricultural biotechnology, like
biotechnology in general, has revolutionized nutritional and food science.
The increasing role of agricultural biotechnology as a significant source for
the global food supply and the interrelation between agriculture, food,
62. See generally Tokar, supra note 11; Berger supra note 10.
63. See generally Sasson, supra note 18; Persley & Lantin, supra note 48; Ryan-
Harshman, supra note 30; COUNCIL FOR BIOTECHNOLOGY INFORMATION,
http://www.whybiotech.com/ (last visited Mar. 4, 2012) (an industry think-tank of
leading agricultural biotechnology companies committed to the promotion of
biotechnology and its benefits).
64. See generally ECONOMIC AND SOCIAL ISSUES IN AGRICULTURAL
BIOTECHNOLOGY (R.E. Evenson et al., eds., 2002); KRIMSKY & WRUBEL, supra note
27; Tokar, supra note 11; CARY FOWLER & PAT MOONEY, SHATTERING: FOOD,
POLITICS AND THE Loss OF GENETIC DIVERSITY (1990).
65. In many indigenous and local communities, there is no stark line of distinction
between food and medicine. On a general conceptual level, where hunger is construed
as a disease, food is a cure. Beyond that, the ecological harmony prevalent in the
indigenous conceptual worldview extends to the fusion or unity of purpose between
food and medicine. On the connection between food, culture and medicine, see
Pascalev, supra note 58, at 588.
66. Ryan-Harshman, supra note 30, at 845.
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nutrition, health and medicine makes agricultural biotechnology a critical
aspect of public health discourse.
Food security and food safety provide a strong foundation for disease
prevention. Also, they are crucial incentives for prolonging life, as they
provide an appropriate basis for organized effort by the community or
population for informed choices toward a healthy lifestyle. Consequently,
food security and food safety are critical to public health. Although the
present analysis focuses on the public health ramifications of food security
and food safety, it bears mentioning that public health transcends, and is
not limited to, the two subjects.67 The central focus of public health is the
prevention of diseases through strategic interventions aimed at the
promotion of healthy lifestyles, informed choices and general surveillance
of potential threats to the health of the population.
We have already noted that the extent to which agricultural
biotechnology promotes food security is dubious, or at best uneven, in
relation to different elements of food security. Opinion on biotechnology's
impact on food safety is equally conflicted. A positive alignment between
agricultural biotechnology and food safety translates into a positive impact
on public health. Conversely, if we posit that products of agricultural
biotechnology or food biotechnology and GMOs in general are not safe
foods, then, of necessity, agricultural biotechnology's impact on public
health would be potentially negative.
D. Chemicalization ofAgriculture
Food safety concerns over the products of agricultural biotechnology
are integral aspects of reservations over the latter's environmental impact
and general concern about its sustainability. 6 9 In this regard, it is not
unusual to lump these concerns with more enduring public health worries
over the increased chemicalization of agricultural production. Agricultural
biotechnology is often lumped together with other variants of what has
been called conventional agriculture, which is characterized by intense
mechanization, scientific plant breeding, hybridization and severe use of
agrochemicals for herbicidal and pesticidal ends. In terms of its
67. See Bayer, supra note 6 at 28-29.
68. Id. See also Constitution of The World Health Organization (Preamble), WORLD
HEALTH ORGANIZATION, http://www.searo.who.int/LinkFiles/About SEARO const.pdf
(last visited Mar. 4, 2012). For a classical conceptualization and examination of the
concept of public health, see C-E. A. Winslow, The Untilled Field of Public Health 51
SCIENCE 1306, 23-24 (1920).
69. See generally Miguel Altieri, Genetic Engineering in Agriculture: The Myths,
Environmental Risks and Alternatives, MINDFULLY (2001), http://www.mindfully.org/
GE/GE2/GE-Ag-Myths-Risks-Altieri.htm; Richard Hindmarsh, The Flawed
Sustainable Promise of Genetic Engineering, 21 THE ECOLOGIST 196 (1991).
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mechanization and industrial appeal, agricultural biotechnology shares
common features with its precursors. However, with regard to its emphasis
on genetic engineering, agricultural biotechnology marks a significant
evolution in conventional agriculture.
Major criticisms of conventional agriculture during the period
preceding the full-blown introduction of genetic engineering centered on
excessive chemicalization and mechanization of the agricultural process,
especially at the wake of the defunct Green Revolution.70 Concerns over
the environmental impact, sustainability, and general reservations regarding
the escalation of costs of agro-inputs constituted the albatross of the Green
Revolution initiative.7 1 In addition, scientists have linked chemical
fertilizers and the introduction of excess nitrogen to water systems with an
increase in carcinogens in the environment and, consequently, the rate of
cancer in the population.72 Overall, even though the Green Revolution
accomplished, to some extent, the increased production of high-yielding
varieties (HYVs) of target crops to address global hunger and food crisis in
the post-World War II period, the overall social cost of chemicalized
agriculture remains a matter of continuing inquiry.
In a way, genetic engineering-driven agricultural biotechnology
marks a remarkable shift in the scientific template of agricultural
innovation. However, there appears to be no dedicated attempt to explore
the extent to which agricultural biotechnology is distinguishable from its
precursor and other forms of conventional agriculture. It is hardly
surprising that most of the criticism of the failed Green Revolution has
been transferred to agricultural biotechnology - and for a good reason.
70. See Conway supra note 42, at 44-45; see also Gonzalez, Trade Liberalization,
supra note 11, at 423; VANDANA SHIVA, THE VIOLENCE OF THE GREEN REVOLUTION:
THIRD WORLD AGRICULTURE, ECOLOGY AND POLITICS (1991); STRUCTURAL
ADJUSTMENT, THE ENVIRONMENT AND SUSTAINABLE DEVELOPMENT (David Reed ed.,
1996).
71. Id.
72. See Daniel Peer, The Toxic Consequences of the Green Revolution, US NEWS &
WORLD REPORTS (July 7, 2008), http://www.usnews.com/articles/news/world/2008/07/
07/the-toxic-consequences-of-the-green-revolution.html (stating many critics of the
Green Revolution refer to the negative environmental impact of the excessive use of
chemical fertilizers, especially on ground water and on the food chain with
consequence in the escalation of cancer, lupus, and several immune diseases, as well as
alleges and asthma); see also Peter Rosset, Joseph Collins, and Frances Moore Lapp6 ,
Lessons from the Green Revolution: Do We Need New Technologies to End Hunger?,
TIKKUN MAGAZINE, March/April 2000, at 52, available at http://www.biotech-
info.net/lessons.html (last visited Mar. 4, 2012) (stating some associate the use of
chemical fertilizers as part of corporate consolidation between agricultural, chemical
and petro-chemical industries' dominance in global grain supplies and food production,
a situation that has continued in the current era of genetic engineering and modem
agricultural biotechnology).
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However, such wholesale transfer of fault and general conflation of the
internal dynamics of conventional agriculture have not allowed for a
dispassionate investment of effort to truly appraise the nature of changes in
agricultural production brought about by full-blown genetic engineering.73
The vociferous nature of the exchange between promoters and opponents
of agricultural biotechnology is one that hardly accommodates a
dispassionate attempt to scrutinize those claims with the benefit of the
doubt.
For instance, agricultural biotechnology is often portrayed as an
alternative to the chemicalized agriculture of the Green Revolution era.74
The argument is that through genetic engineering, agricultural
biotechnology has potential to reduce the use of chemicals for agricultural
purposes. Assuming this claim has any iota of credibility, the reduction of
chemicals from the agricultural process will disburden it from extensive
public health and food safety concerns that have continued to dog industrial
agriculture. Secondly, as already noted, genetic engineering has real
potential to facilitate radical reduction in the use of water for agricultural
purposes. Similarly, proponents argue that agricultural biotechnology
potentially promotes the use of less land to grow more food. Assuming
these claims to be conclusive or even tenable, their overall "social
economics of scale" for human agricultural endeavor would warrant serious
consideration for the future of agriculture. The reality, however, is that like
most scientific claims, the devil lies in the details.
In addition, most claims in the arena of biotechnology are readily
matched with counterclaims. For example, casting doubt over the potential
of biotechnology to reduce the use of agricultural chemicals, it has been
noted that, "the use of chemical inducers to activate desired traits is a
feature of agro-biotechnology that dampens the hope of respite from
chemicalized agriculture. Contrary to its promoters' claims, agro-
biotechnology is implicated in the increased use of agro-chemicals." 75
Similarly, the potential of agricultural biotechnology to use less land,
thereby potentially freeing up land for other uses, is admittedly an
economic efficiency model. But that feat can be counterbalanced by
73. The role of corporate interests in the promotion of the Green Revolution and the
enthronement of what analysts have called petro-dependant or chemical farming was
one of the Achilles' heels of the Green Revolution. In comparison to the Green
Revolution era, the contemporary epoch of genetic engineering-centered agricultural
biotechnology is virtually shaped by corporate interests with very limited public
involvement. In addition to other criticism of genetic engineering, this state of affairs
justifies the tendency to conflate Green Revolution dynamics with genetic engineering
and agricultural biotechnology.
74. See KRIMSKY & WRUBEL, supra note 27, at 213; Oguamanam, supra note 14, at
225; see generally Ryan-Harshman, supra note 30.
75. Oguamanam, supra note 15, at 225 and n. 49.
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concentration of agricultural biotechnology on a few monocrops at the
expense of agro-biodiversity, which encourages the growing of diverse
varieties of agricultural products through several methods 6 and in different
ecological and diverse socio-cultural settings. Because of its relative
novelty, the inchoate nature of scientific claims in general, as well as the
passionate propaganda with which agricultural biotechnology is promoted
and resisted, it has not been easy to accurately audit each aspect of its
claims that warrant being taken more seriously than others.
Indeed, the complex and generally intricate nature of the scientific
and technological processes involved in agricultural biotechnology do not
lend themselves to cherry-picking one process or outcome over others. For
instance, genetic engineering interventions may accomplish storage or
marketing objectives such as elongating the shelf life and promoting
efficient handling of sensitive fruits and vegetables. However, the overall
health and environmental ramifications of such fruits and vegetables and
the process of their production may not be immediately evident. A full-
scale exploration of the real and potential impact of genetic engineering
and agricultural biotechnology is outside the scope of this paper.
The prevailing reservations and skepticisms over genetic engineering
have not retarded its advancement. The continued entrenchment of
agricultural biotechnology in global food production is a reality that can no
longer be wished away. However, as with new technologies and scientific
innovations, the imperative for a prudent and critical approach to genetic
engineering is no less compelling. Genetic engineering in particular, and
agricultural biotechnology generally, present significant opportunities in
specific areas that are open to constructive exploitation. In this regard, the
next section examines the potential impact of agricultural biotechnology on
aspects of the global public health crisis.
IV. AGRO-BIOTECH AND GLOBAL PUBLIC HEALTH
As noted already, lack of access to essential drugs for populations in
need appears to dominate contemporary discussion on the global public
health crisis. 7 7 Similarly, crisis management of specific pandemics through
76. Id. at 223 and n. 37.
77. See generally Richard E. Gold, Gene Patents and Medical Access, 49 INTELL.
PROP. F. 20 (2009); Alexander G. Watson, International Intellectual Property Rights:
Do TRIPS' Flexibilities Permit Sufficient Access to Affordable HIV/AIDS Medicines in
Less-developed Countries?, B.C. INT'L & COMP. L. REv. (2009); Maxwell R. Morgan,
Medicines for the Less-developed World: Promoting Access and Innovation in the Post
TRIPS Environment, 64 U. TORONTO FAC. L. REV. 45 (2006); James Thuo Gathii,
Rights, Patents, Markets and the Global AIDS Pandemic, 14 FLA. J. INT'L L. 261
(2002); Thomas K. Mirabile, AIDS, Africa and Access to Medicines, 11 DETROIT COLL.
L. J. INT'L L. 175 (2002); and supra note 2 and accompanying text.
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sometimes ad hoc manufacture and dispensing of required vaccines and
other epidemiological interventions define recent public health
interventions on a global level. 7 8 Although these models of public health
interventions incorporate therapeutic and preventive elements, the latter is
at the core of the public health imperative. Historically, occasional
outbreaks of diseases that constitute threats to public health require both
therapeutic and preventive interventions.79 In these contexts, the essence of
therapeutic intervention on affected members of the population is
preventive, especially in regard to epidemics and other infectious diseases
that expose the population to danger. When an infected member of the
population is treated, the risk of the spread of the disease to others is
contained. Public health is preventive health.80  Most of preventive
"medicine" is about encouraging a physically active and generally healthy
lifestyle. This is often accomplished through various forms of public-
centered education on personal and public hygiene, habit and general
promotion of prudent choices in diverse spheres that have ramification for
overall health and well-being of both the individual and the community.
Apart from an occasional outbreak of diseases that are not necessarily
linked to a population's lifestyle choices, significant pressures on today's
public health are lifestyle-driven. For instance, "mutual relationships
among environmental, social variables, nutrition, and public health, and
nutritional deprivation" have long been implicated as factors that
predispose a population to disease.8' According to the World Health
Organization (WHO), nutritional deficiency is a driver of adverse health
outcomes and it makes other stressors such as infectious disease more
potent. The organization describes "malnutrition as the greatest single risk
factor contributing to the global burden of disease."82
The Food and Agriculture Organization (FAO) is a specialized
agency of the United Nations with mandates that include improving the
quality of nutrition, food and agricultural supplies and the general standard
78. See supra note 3 and accompanying text; see also Thomas Pogge, Human Rights
and Global Health: A Research Program, 36 METAPHILOSOHPY 182, 183 (2005).
79. See OBIJIOFOR AGINAM, GLOBAL HEALTH GOVERNANCE: INTERNATIONAL LAW
AND PUBLIC HEALTH IN A DIVIDED WORLD 46-59 (2005).
80. See Bayer, supra note 6, at 28.
81. Richard D. Semba, Nutrition and Development: A Historical Perspective, in
NUTRITION AND HEALTH IN DEVELOPING COUNTRIES 6 (Richard Semba & Martin W.
Bloem eds., 2002).
82. ROLAND LABONTE, TED SCHRENCKER, DAVID SANDERS & WILMA MEEUS,
FATAL INDIFFERENCE: THE G8 AFRICA AND GLOBAL HEALTH 96 (2004), available at
http://www.idrc.ca/en/ev-45682-20 1-1-DOTOPIC.html.
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of living of local populations.83 It estimates that the number of
undernourished peoples in the world rose from 923 million in 2007 to 963
million in 2008, and continues to grow in the wake of current global food
crises. 84 FAO states that 907 million of those hungry in 2007 lived in less-
developed countries and "[o]f these, 65 percent live in only seven
countries: India, China, the Democratic Republic of Congo, Bangladesh,
Indonesia, Pakistan and Ethiopia.""
Despite notable progress in Southeast Asia, especially in Thailand and
Vietnam, "nearly two-third of the world's hungry live in Asia (583
million)."86 Sub-Saharan Africa has the unenviable record of having the
highest proportion of undernourished people, with one in three people
chronically hungry, a total of 236 million.87 Overall, Asia and Sub-Saharan
Africa post the highest rates of child malnutrition in the world. Multiple
combinations of interrelated but innumerable factors - including illiteracy,
poverty, high food prices, political instability, harsh climatic conditions,
and the recent economic downturn - account for this dangerous and
gloomy profile.
The FAO criterion for undernourishment is premised on the daily
intake of calories at a level regularly "insufficient to meet dietary energy
requirement[s]."88 In Fatal Indifference, Laponte et al. point out that the
FAO criterion "does not refer to shortages of micronutrients such as iodine,
vitamin A and iron that may be critical for health, and which affect much
larger numbers of people."89 Malnutrition is a significant factor in the high
rate of infant and maternal mortality, as well as the generally low life
expectancy in many less-developed countries. The developmental and
economic impact of malnutrition as a public health challenge to less-
developed countries is recognized at diverse international institutions and
ad hoc global policy forums, notably the United Nations, the WHO, FAO,
UNICEF, the World Bank, and even the G8 of the world's industrialized
nations.90
83. See Statement of Mandate, FOOD AND AGRICULTURE ORGANIZATION OF THE
UNITED NATIONS, http://www.fao.org/about/mission-gov/en/ [hereinafter Statement of
Mandate]; see also Shaw, supra note 11, at 67-68.
84. See Number of Hungry People Rises to 963 Million, FOOD AND AGRICULTURE
ORGANIZATION OF THE UNITED NATIONS (Dec. 9, 2008), online at
http://www.fao.org/news/story/en/item/8836/ [hereinafter Hungry People]. These




88. LABONTE ET AL. supra note 82.
89. Id. at 96.
90. See generally id.
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Strikingly, the United Nations Millennium Development Goals
(MDGs), which outline the international development objectives projected
to be realized by the year 2015, identify key aspects of the factors linked to
the public health crisis in less-developed countries. 91 These aspects include
reduction of extreme poverty and hunger, child mortality, improvement of
maternal health, combating specific disease epidemics, promotion of
universal primary education, gender equality and empowerment of women.
These key aspects bear direct relevance to nutritional health. For example,
poverty has a chicken-and-egg relationship with illiteracy. Jointly and
severally, they escalate the cycle of ignorance that undermines the
promotion and management of a healthy maternal and infant lifestyle for
the collective health of the population. The final part of the MDGs focuses
on the forging of a global "partnership of development." This omnibus part
of the MDG centers on collaborative strategies between developed and
less-developed countries, which target development initiatives aimed
primarily at poverty eradication.
Similar to the sentiments in the MDGs, the G8 of industrialized
nations has made a commitment to International Development Goals
(IDGs) in regards to, among other things, tackling the scourge of poverty in
less-developed countries. 92 The G8 seeks to reduce the number of children
less than five years old who are underweight, which is its key indicator of
poverty. The G8 Africa Action Plan mentions food security in the context
of economic development, and includes the adoption of new
biotechnologies. 9 3 The suitability of agricultural biotechnology for less-
developed countries, as well as the appropriate modality for its uptake,
remains a policy challenge. So far, this has been approached in multiple
combinations of development assistance, agricultural assistance, food aid,
emergency food reliefs and various other means.
Prevailing inequities in the international trade framework and the
global political economics of agriculture have cast a dubious cloud on the
sincerity and true motives of agricultural assistance and food aid for less-
developed countries. 94 Food aid and agricultural assistance critics have
91. See United Nations Millennium Development Goals, UNITED NATIONS,
http://www.un.org/millenniumgoals/ (last visited Mar. 4, 2012).
92. See LABONTE ET AL., supra note 82, at 98.
93. See G8 African Action Plan, SOMNET KANANASKIS SUMMIT CANADA (2002),
http://www.canadainternational.gc.ca/g8/assets/pdfs/2002kananaskis/afraction-en.pdf.
The African Action Plan was adopted by the G8 leaders in Kananaskis, Alberta,
Canada, in 2002 pursuant to the New Partnership for Africa's Development (NEPAD).
The latter is an Africa-driven initiative to identify and tackle priority areas of the
continent's development challenges.
94. See Gonzalez, Trade Liberalization, supra note 11, at 470-71; LABONTE ET AL.,
supra note 82, at ch. 5 and 7; cf Shaw, supra note 11.
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insinuated a number of ulterior motives tenable under those initiatives. 9 5
As between the recipient countries and their local producers on the one
hand, and the donor countries and their agro-biotech companies on the
other, it is not clear who actually benefits from food aid or other forms of
agricultural assistance.96 Also, it is hard to ascertain whether food aid and
agricultural assistance advances food security in the recipient or in the
donor countries.97
Similar sentiments apply in regard to the perceived negative impact of
emergency food relief. Akin to the tendency of big pharmaceutical
companies to donate patented drugs that are on the verge of expiration to
needy populations, 98 donors capitalize on food aid for "food dumps" to
offload surplus agricultural products to circumvent WTO anti-dumping
rules.99 Continued agricultural subsidies in developed countries destroy the
export capacity of food aid recipients, a situation that raises doubts on the
altruistic foundation of food aid. Non-emergency food aid presents a
potential threat to food security in recipient countries. They open up
markets for donor countries as well as upset the traditional pattern of food
production in recipient countries. 00
The public health impact of nutritional deficiencies in less-developed
countries assumes a crisis dimension.'0o Despite the reservation trailing the
nature of agricultural biotechnology and the suspect nature of agricultural
assistance and GMO food aid, agricultural biotechnology is an attractive
incentive to tackle malnutrition as the "greatest single risk factor
contributing to the global burden of disease."1 02  The potential of
95. According to LABONTE ET AL., supra note 82, at 100, food "aid is motivated at
least partly by a desire to absorb domestic production surpluses." See also Shaw, supra
note 11, at 21.
96. See generally Shaw, supra note 11.
97. See LABONTE ET AL., supra note 82, at ch. 7, which explores the negative impact
of agricultural subsidies by industrialized countries on agricultural production, food
security and export potentials of recipient countries.
98. See Shah, supra note 3.
99. LABONTE ET AL., supra note 82, at 102.
100. See Shaw, supra note 11, at 28-29; LABONTE ET AL., supra note 82 at 101.
101. See generally Sasson, supra note 18; LABONTE ET AL., supra note 82; MEDECINS
SANs FRONTIERES, MALNUTRITION: HOW MUCH is BEING SPENT? 3 (Nov. 2009),
available at http://www.msf.org/source/malnutrition/2009/NutritionHowMuchisBeing
Spent.pdf (last visited Mar. 4, 2012). For a discussion of how rampant malnutrition is a
factor in the mental, physical and intellectual development of more than 100 million
children globally and how parental nutrition education is superior to large, politically
motivated feeding or aid programs, see generally WORLD BANK, REPOSITIONING
NUTRITION AS CENTRAL TO DEVELOPMENT: A STRATEGY FOR LARGE-SCALE ACTION
(2006), available at http://siteresources.worldbank.org/NUTRITION/Resources/
281846-11 31636806329/NutritionStrategy.pdf.
102. See LABONTE ETAL., supra note 82, at 96.
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agricultural biotechnology as a tool to alleviate malnutrition in less-
developed countries and among less-endowed populations is only one
aspect of its possible impact on public health. In other applications, such as
biopharming, agricultural biotechnology, and especially genetic
engineering, are used to exploit living organisms for the production of
pharmacologically active substances. In the context of other complex
disciplinary convergences, genetic engineering facilitates the "pharming"
of crucial organs for complex medical procedures and pharmaceutical
R&D. Agricultural biotechnology is an integral aspect of the twenty-first
century medical revolutions in ways that reinforce the traditional affinity
between agriculture, food and medicine.'03
A. The Case for Bio-fortification and Functional Food: Two Analogies
Of particular interest in this article is the role of agricultural
biotechnology in the development of so-called functional food. In the
words of one analyst,
[flood fortification to improve the nutritional quality of
diets was first practised during the mid-1990s. . . . The
potential of foods to provide health benefits is known as
functional food research, which is somewhat of a
misnomer because all foods are functional. The term
nutraceuticals may be more appropriate, even though it
tends to medicalize the food supply. Biotechnology,
specifically genetic engineering, will assist the food
industry in capturing the highest market potential for
functional food.104
Besides market capture for functional foods, agricultural
biotechnology is potentially a strategic resource for reversing the negative
effect of malnutrition as a significant risk factor to the global public health
crisis. To accomplish this objective, especially for less-developed
countries and other disadvantaged or malnourished populations, we must of
necessity de-emphasize the market economic dynamics, the political
economics of agriculture for the developmental imperative, and the urgent
intervention considerations invoked by the association of malnutrition with
public health crises.' 0 5 That way, we are more likely to temper, if not get
103. See generally Sasson, supra note 18; Ryan-Harshman, supra note 30; see also
KUHNLEIN & TURNER, supra note 58.
104. Ryan-Harshman, supra note 30, at 847.
105. Many critics of agricultural biotechnology or industrial agriculture (e.g. Tokar,
supra note 10; Gonzalez, Trade Liberalization, supra note I1; Conway, supra note 42;
Altieri, supra notes 38 & 69; FRANK ELLIS, AGRICULTURAL POLICIES IN DEVELOPING
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around, most of the existing obstacles, including resistances to GMOs and
products of agricultural biotechnologies. From the FAO data highlighted
above,' 06 the statistics of malnutrition's impact on the public health of the
less-developed countries of Africa and Asia depict the problem in a crisis
mode. It is a problem requiring an urgent intervention. This "crisis
interventionist approach" in the use of agricultural biotechnology to
address the negative public health impact of malnutrition on less-developed
countries can be analogized to two patterns of response to public health
challenges at various national and global levels, namely the anti-obesity
campaigns in developed countries and the global public good approach to
health provisions.
1. The Anti-obesity Campaign
Various governments of the industrialized world, including the U.S.,
Canada, France, U.K. and most other European countries have responded
to the "obesity epidemic" that has arisen in those countries since the
1990s.' 07 Although the WHO recognized obesity as a global epidemic that
constitutes an ongoing threat to public health, countries at highest risk are
those in the affluent regions of the world. Like malnutrition, obesity is
mostly a lifestyle-based crisis, even thought it has genetic ramifications in
some cases.
Leading the way, the WHO issued its promotional document on the
dangers of obesity and related diseases titled World Strategy for Food,
COUNTRIES (1992); YOUNG, supra note 41) agree that both forms of agricultural
production jointly or severally advance the neoliberal political economics of agriculture
and create a culture of dependence on external multi-national agro-allied corporations
by less-developed countries for food. Indeed, in order to adapt agricultural
biotechnology for meaningful crisis intervention, we need to create a platform in which
the application of benefits of agricultural biotechnology is need-driven, rather than
market-driven.
106. See Hungry People, supra notes 84 and 85.
107. The World Health Organization reports that in 2008 1.5 billion adults were
overweight-and nearly 500 million of these were obese. Obesity and Overweight,
WORLD HEALTH ORGANIZATION (March 2011), http://www.who.int/mediacentre/
factsheets/fs3l l/en/. For a review of the latest CDC report on obesity across the U.S.,
see Miranda Hitti and Louise Chang, How Fat is Your State?, WEBMD (July 8, 2009),
http://www.webmd.com/diet/news/20090708/how-fat-is-your-state (reporting that
according to the 2009 US Center for Disease Control (CDC) figures, 26.1% of US
population was obese in 2008, compared to 25.5% the year before); see also OECD,
HEALTH AT A GLANCE 2009: OECD INDICATORS (2009), available at
http://www.oecd.org/dataoecd/55/2/44117530.pdf (stating the median percentage for
the prevalence of obesity in OECD countries is almost 15 percent according to
2006/2007 figures and the US has the highest percentage of obesity amongst the 30
OECD countries).
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Physical Exercise and Health.08 According to the WHO, "[t]he strategy
addresses two of the main risk factors for noncommunicable diseases,
namely, diet and physical activity, while complementing the long-
established and ongoing work carried out by WHO and nationally on other
nutrition-related areas, including malnutrition, micronutrient deficiencies
and infant and young-child feeding." 09 In some industrialized countries,
more than half of the population falls within the overweight and obesity-
borderline categories. For the first time in those countries, overweight and
obesity constitute significant threats to life expectancy, resulting in health
and social impacts on a comparable scale to other entrenched public health
challenges, notably smoking, for example."10 Also, like malnutrition, the
impact of obesity on overall population health is hardly an isolated one.
"Obesity is a risk factor for many chronic illnesses, particularly heart
diseases and diabetes.""'
At different national governmental levels, most developed countries
responded to the obesity epidemic through the institutionalization of a
combination of various public health education and lifestyle awareness
programs. These include revisions of the dietary and physical exercise
regimen, especially for youths and school-age children in public schools
and elsewhere, labeling regimes for food and food-processing industries,
including restaurants and eateries.112 Also, these countries embarked on
dedicated education and various campaigns using the diverse new media to
sensitize the public on the dangers of obesity and the lifestyles that
108. WORLD HEALTH ORGANIZATION, WORLD STRATEGY ON DIET, PHYSICAL,
ACTIVITY AND HEALTH (2004), available at http://www.who.int/dietphysicalactivity/
strategy/eb 1344/strategy english web.pdf.
109. Id.
110. For instance, Statistics Canada reports that the number of obese Canadians
doubled between late 1978 and 2005 and has continued to go up. See Statistics Canada,
Obesity - the key figures according to Canada's statistics, UNIVERSITE LAVAL,
http://obesity.ulaval.ca/obesity/generalities/prevalence.php (last visited Mar. 4, 2012);
for more up-to-date statistics, see Obesity in Canada a Snapshot, PUBLIC HEALTH
AGENCY OF CANADA (2009), http://www.phac-aspc.gc.ca/publicat/2009/oc/pdf/oc-
eng.pdf.
111. Indicators of Well-Being in Canada, HUMAN RESOURCES AND SKILLS
DEVELOPMENT CANADA, http://www4.hrsdc.gc.ca/ (last visited Mar. 4, 2012).
112. For example, noting the association of saturated and trans-fat, excess sugar and
calories with obesity, most beverage companies have capitalized on the market niche
for low trans/saturated fat and calorie-/sugar-free brands. On an annual basis, Health
Canada issues Canada 's Food Guide (no longer published, see website), which
highlights suggested national dietary regimen for various age groups as a public health
promotion strategy. For the current guide, see Eating Well with Canada's Food Guide,
HEALTH CANADA, http://www.hc-sc.gc.ca/fn-an/food-guide-aliment/index-eng.php (last
visited Mar. 4, 2012).
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predispose populations to it." 3 Such campaigns have also elicited
innovative responses in both public and private sporting, outdoor and
indoor physical exercise entrepreneurships now enhanced by new
information technologies. These campaigns have also resulted in positive
reactions from the biotechnology, food, beverages and allied industries that
now capitalize on the opportunity to advance R&D on functional and anti-
obese foods and drinks.It 4
The proactive role of many industrialized countries in promoting the
nutritional health of the population pursuant to their anti-obesity public
health programs takes the form of a crisis intervention strategy. Recently,
the current U.S. First Lady, Michelle Obama, unveiled her White House
Legacy Initiative, which is aimed at curbing childhood obesity. Dubbed
the "Let's Move" campaign, it marks a significant renewal of attention to
obesity, in a crisis-intervention fashion, for a country that is said to spend
$150 billion annually on preventable obesity-related diseases.115  In this
crisis mode, objections or traditional libertarian criticisms to state
paternalism and state erosion of citizens' free choice in regard to regulatory
intervention on food and beverages are easily blunted by the overarching
public-regarding objectives that underlie the anti-obesity campaigns.l16
113. For example, the U.S. Congress mandated the Centers for Diseases Control and
Prevention to initiate nutrition and physical activities and related programs as a nation-
wide strategy to tackle obesity and other chronic diseases. In 2006, the CDC published
the first report on the progress of the initiative in 20 states. See generally Sue Lin Yee,
Pam Williams-Piehota, Asta Sorensen, Amy Roussel, James Hersey & Robin Hamre,
The Nutrition and Physical Activity Program to Prevent Obesity and Chronic Diseases:
Monitoring Progress in Funded States, 3(1) PREV. CHRONIC Dis. A23 (2006), available
at http://www.ncbi.nlm.nih.gov/pmd/articles/PMCI500956/pdf/PCD31 A23.pdf.
114. Food product labelling is an important aspect of the work program and mandate
of the United States Food and Drug Administration and the Department of Agriculture,
and their Canadian Counterparts, Health Canada and Canada's Food Inspection Agency
(which administers Canada's Food and Drugs Act and associated regulations). In the
last few decades, the labelling regimes for a number of food items, especially
beverages and general groceries, have been required to include information on
nutritional values, ingredients, calories, fat, trans fat, carbohydrates, cholesterol and
sugar counts.
115. See Editorial, On Michelle Obama's Obesity Campaign, THE SAN FRANCISCO
CHRONICLE, Feb. 10, 2010, at A13, available at http://www.sfgate.com/cgibin/article
.cgi?f=/c/a/2010/02/09/EDQM1BUHO3.DTL.
116. For insight into the ideology-driven debate on state paternalism on citizen's food
choices and related matters, see the self-explanatorily titled book: DAVID HARSANYI,
NANNY STATE: How FOOD FASCISTS, TEETOTALING DO-GOODERS, PRIGGISH
MORALISTS, AND OTHER BONEHEADED BUREAUCRATS ARE TURNING AMERICA INTO A
NATION OF CHILDREN (2007). But see Kenneth Calman, Beyond the "Nanny State":
Stewardship and Public Health, 123(1) PUBLIC HEALTH e6-el0 (2009), available at
http://www.publichealthjrnl.com/issues?Vol=123. (Calman argues that the state has
the duty to preserve the health of the individual and the public and that such a duty
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That approach is comparable to the present proposal to extend the use of
agro-biotech food fortification mechanisms and products to less-developed
countries in order to tackle the public health menace that malnutrition, like
obesity, poses. As already noted, this strategy does not of necessity
dispense with valid objections and lingering criticism of agricultural
biotechnology, especially in the context of less-developed countries. But
pragmatically, from a crisis point of view, the strategy assumes an urgency
that eclipses some, even the most pertinent, of the objections.
2. Global Public Good Approach to Functional Food
The second analogous response is global in scale and scope. As
mentioned earlier, recent discourses on the global public health crisis focus
on lack of access to essential drugs for needy populations." 7 In part, this is
blamed on the unaffordable cost of such drugs as a result of the extant
global intellectual property system. Because of endemic poverty, the
majority of people in the less-developed world cannot pay for essential
drugs." 8 Consequently, pharmaceutical R&D does not target their health
needs."' In the hard and cold economics of pharmaceutical R&D, it does
not matter that not even "10% of global health research spending is devoted
to the health needs of 90% of the world's population." 20 Consequently,
the public health needs of less-developed countries, especially in regard to
access to essential drugs, take the status of "global public goods." The
latter refers to those goods that cannot be provided by market forces.121
would often necessitate restricting citizen's choices). In November 2010, the Board of
Supervisors of the California City of San Francisco voted overwhelmingly to ban the
practice by restaurants to offer children free toys with meals containing more than
prescribed levels of calories, sugar and fat, like the so-called Happy Meale, one of the
niches of the global fast food giant, McDonald's. The ban, which is sure to outrage
libertarians, is scheduled to take effect at the end of 2011. See Joe Eskenazi, San
Francisco Bans Happy Meal, SAN FRANCISCO WEEKLY Nov. 2, 2010, available at
http://blogs.sfweekly.com/thesnitch/2010/l /happymealbanpasses_-_with.php.
117. See generally supra note 2 and accompanying text.
118. Id.
119. See DRAHOS & BRAITHWAITE, supra note 5, at 167-68: ("[p]atent-based R & D
is not responsive to demand, but to ability to pay").
120. Els Toreele, Martine Usdin & Pierre Chirac A Needs-Based Pharmaceutical
R&D Agenda for Neglected Diseases, WORLD HEALTH ORGANIZATION (July 31, 2004),
http://www.who.int/intellectualproperty/topics/research/Needs%20based%20R&D%20
for%20neglected%20diseases%20Els%2OPierre%2OMartine.pdf; see also P. Trouiller,
P. Olliaro. E. Torreele, J. Orbinski, R. Laing & N. Ford, Drug Development for
Neglected Diseases: A Deficient Market and a Public-health Policy Failure, 22:359
(9324) LANCET 2188 (2002) (discussing how tropical diseases are neglected because of
diminutive financial returns).
121. See WORLD HEALTH ORGANIZATION, GLOBAL PUBLIC GOODS FOR HEALTH,
available at http://whqlibdoc.who.int/publications/9241590106.pdf; see also GLOBAL
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Accordingly, since the provision of such goods are outside the capacity of
relevant national governments and market forces, the responsibility to do so
becomes a matter for concerted international effort.12 2
For some analysts, the global public goods argument explains the role
of non-governmental organizations (NGOs), the WHO, and various
national and intergovernmental organizations in the facilitation of access to
essential drugs outside a strict market paradigm to stem public health crises
in less-developed countries. 12 In recent times, there has been a
proliferation of diverse charities, foundations and private non-profit
initiatives that now constitute active players in the public health dynamics
of less-developed countries.124 There is no dearth of literature on the
emergent patterns or forms of private-public partnerships under which
these initiatives operate. For the most part, the essential drugs required to
tackle aspects of public health crises in less-developed countries are subject
to patents held by pharmaceutical companies. Without doubt, these
companies are central to emerging forms of non-market or quasi-market
interventions to the supply of essential medicines to populations in need. 125
Given their high stakes in intellectual property, they are actively engaged in
negotiating forms of private-public partnerships (PPP) in pharmaceutical
R&D, targeting key vaccines and the supply of essential drugs and delivery
of urgent medical relief to needy populations via forms of non-market
interventions.126
The foregoing situation is not entirely different from, and can be
analogized to, the need to extend fortified biotechnology food products (as
global public goods) to tackle malnutrition as a source of the public health
burden in less-developed countries. Agricultural biotechnology, like
pharmaceutical production, is an innovation-intensive enterprise. Like the
pharmaceuticals, most biotechnology products are subject to patents.
PUBLIC GOODS FOR HEALTH: HEALTH ECONOMICS AND PUBLIC HEALTH PERSPECTIVES
(R. Smith, R. Beaglehole, D. Woodward, & N. Drager eds., 2003).
122. For further perspectives on global public goods, including environmental
protection, public health, education, and scientific advancement, see generally Keith E.
Maskus & Jerome H. Reichman, The Globalization of Private Knowledge Goods and
the Privatization of Global Public Goods, 7 J. INT'L ECON. L. 279 (2004).
123. See generally Briefing Paper, Oguamanam, Oriola, supra note 3.
124. See Oguamanam, supra note 3 (referencing such organizations as The Bill &
Melinda Gates Foundation, The William Jefferson Clinton Foundation, the Wellcome
Trust, Universities Allied for Essential Medicines, Medicines Sans Frontiers and
several disease specific initiatives such as the Roll-Back Malaria Partnership, Drugs for
Neglected Diseases Initiative, and the Global Network for Neglected Tropical Disease
Control and the United States Presidential Emergency Plan for AIDS Relief).
125. See generally Oguamanam, supra note 3.
126. Examples include Advance Market Commitments, Product Development
Partnerships, Priority Review Voucher, etc. For a general review of these and other
frameworks, see Briefing Paper, supra note 3.
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Given that most of the malnourished population in less-developed countries
lives on less than one dollar per day, they are unable to afford functional
biofortified foods necessary for mitigating their endemic malnutrition. 2 7
Agricultural-biotechnology companies control most of the patents in the
area of GM food products. These companies have the potential to assist in
the development and delivery of targeted biofortified or functional foods as
public health incentives. They are critical stakeholders on how these
initiatives are implemented. Naturally, agricultural biotechnology
companies are interested actors in the programs presently underway
regarding the development and dissemination of biofortified food crops
targeting populations in need.
Intervention on a global scale for hunger-containment reflects a
melange of crisis-management and broader socio-economic policy
approaches. Consequently, the global food and agricultural landscape is
buffeted by a complex array of bureaucracies operating at multifarious
levels, including intergovernmental, regional, national, non-governmental,
private and diverse civil society initiatives. 2 8 Given the technology and
research-intensive nature and obligate interdisciplinarity of food and
agricultural subject matters, the global agricultural and food question is
often one of political economics. Inherently, within that matrix are the
interrelated issues of equity, access, markets, and development in the
context of the tension between public and private interests in agricultural
and food production. Of all the variegated global food and agricultural
institutions ably discussed in John Shaw's recent work, Global Food and
Agricultural Institutions, perhaps none more than the Consultative Group
on International Agricultural Research (CGIAR) reflects the practical
imperative for a non-market or public-goods approach in the extension of
the benefit of agricultural biotechnology as public health incentives in less-
developed countries. 129
B. The HarvestPlus Model
The CGIAR was established in 1971 as a private-public initiative that
manages the use and access to samples of plant genetic resources (PGRs) in
global ex situ seed banks for agricultural research, including plant
127. Critics of agricultural biotechnology harp on the twin subjects of access and
affordability. For example, Altieri, supra note 38, at 2 observes: "[m]ost
biotechnological innovations available today bypass poor farmers: first because these
farmers cannot afford the seeds that are protected by patents owned by biotechnology
corporations, and second, because this modem technology is not adapted to the
marginal environments where resource-poor farmers live."
128. See generally Shaw, supra note 11.
129. Shaw, supra note 11, at 88-89.
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breeding. 130 The principal sponsors/financiers of CGIAR include the FAO,
the International Fund for Agricultural Development (IFAD), the United
Nations Development Program (UNDP), the World Bank, private charities
and various national governments.'31 It is worth noting that these publicly
held PGRs in ex situ global seed banks were historically sourced from
centers of biodiversity, mainly less-developed countries. CGIAR held "the
largest single collection of plant genetic materials, comprising 650,000
accessions (about 10 percent of the world's collection)" until 2008.132 The
CGIAR describes itself as "a strategic alliance of countries, international
and regional organizations, and private foundations supporting 15 33
international agricultural Centers [IARCs] that work with national
agricultural research systems and civil society organizations including the
private sector." 34 These federating IARCS exist as autonomous entities
but are jointly committed to the CGIAR mission of providing "the world's
largest investment in generating public goods for the benefit of poor
agricultural communities in the developing countries."115 According to the
CGIAR, the alliance "applies cutting-edge science to foster sustainable
agricultural growth" to reduce poverty and enhance human, agricultural
and environmental well-being that benefits the poor.136
CGIAR's activities focus on five thematic strategies and priorities
aimed at the delivery of the benefits of agricultural innovation to the needy
in less-developed countries. They include sustainable approaches to
agricultural production, promotion of national agricultural research
capacity, germplasm taxonomy, collation, conservation and dissemination,
and policy research on interrelated agricultural subject matters, such as
food, health, new technologies and natural resources conservation. 13 7 With
the complement of the International Food Policy Research (IFPRI), one of
its federating IARCs, CGIAR's policy research has recently garnered
traction in the areas of poverty alleviation, eradication of hunger and
malnutrition. Under the auspices of its programmatic model, the Global
Challenge Program, CGIAR launched the Generation Challenge Program
aimed at extending the benefits of biotechnology, especially molecular
130. Id. at 88, 153.
131. Id. at 90.
132. Id. at 161.
133. 13 of these IARCs are located in less-developed countries. See Shaw, supra
note 11, at 153.
134. Oguarnanam, supra note 61, at 282, n. 42.
135. Shaw, supra note 11, at 153.
136. Who We Are, CGIAR, http://www.cgiar.org/who/index.html (last visited Mar. 4,
2012).
137. See CGIAR SCIENCE COUNCIL, SUMMARY OF REPORT ON SYSTEM PRIORITIES
FOR CGIAR RESEARCH 2005-2015 (2005), available at http://www.sciencecouncil.
cgiar.org/fileadmin/user-upload/sciencecouncil/Reports/SCPriorities prFinal l-r_.pdf.
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biology, to the global stock of genetic resources and putting them at the
disposal of needy families and farming communities to plug the gap
between hungry and healthy families.' 38
To shore up its dwindling financial fortune in the 1990s and, in part,
to "draw more attention to agriculture by pointing out its close links with
high-profile issues, such as health, the environment and conflict,"' 3 9 the
CGIAR embarked on a conscious re-branding effort that resulted in the
near-renaming of IARCs as "Future Harvest Centers." Essentially, the
Future Harvest [FH] brand was the coordinating platform for launching the
CGIAR effectively into the biofortification campaign. The FH highlighted
the link between agriculture and myriad development issues, including the
public health impact of nutritional deficiencies and the remedial role of
biotechnology, specifically via the biofortification option.
Unfortunately, FH was the first casualty of its own success. Its social
and development marketing quickly lost favor with CGIAR leadership and
key donors. Consequently, the FH brand was disbanded. In-house post-
mortem reflection on the early demise of FH initiative implicates internal
intrigues within the federating IARCs under the CGIAR umbrella.14 0 It
also points to perceived conflict between resource mobilization and
communication. The latter is quite instructive as it may provide a clue to
donor disaffection for the FH modus operandi. It is possible that given
FH's emphasis on social marketing and development, some donors were
not pleased that proprietary interests in the PGRs innovations within the FH
agenda were completely out of the equation. CGIAR is a private-public
partnership and terms of access to the benefits of its innovation remain a
contentious issue. FH's modus operandi and orientation toward social
marketing and development may not have adverted the historic delicate
balance that characterizes debates over CGIAR's oversight or role in regard
to use and access to PGRs in ex situ seed banks under its jurisdiction.141
Private stakeholders within the CGIAR have yet to dissociate their interest
from proprietary control of research outcomes.
138. See The Generation Challenge Programme, CGIAR, http://www.generationcp.
org/ (last visited Mar. 4, 2012).
139. Nathan Russell & Ruth Raymond, Collective Communications on the CGIAR: A
Short History ofa Long Standing Endeavour, CGIAR, http://www.cgiar.org/pdf/scw
HistoryofCollective%20Communications.pdf (last visited Mar. 4, 2012).
140. See id.
141. For instance, Mgbeoji and others suggest that CGIAR was set up and allowed
free hand to access global gene banks to facilitate the funneling of the South's PGRs to
the North's industrial agricultural complex, which could no longer be guaranteed at the
formal end of colonialism. See IKECHI MGBEOJI, GLOBAL BIOPIRACY PATENTS, PLANTS
AND INDIGENOUS KNOWLEDGE 106 (2006); see also WILLIAM LESSER, SUSTAINABLE
USE OF GENETIC RESOURCES UNDER THE CONVENTION ON BIOLOGICAL DIVERSITY:
EXPLORING ACCESS AND BENEFIT SHARING ISSUES 99 (1997).
[VOL. 7290
TOWARD A CONSTRUCTIVE ENGAGEMENT
Despite the demise of FH strategy, the CGIAR, in alliance with its
affiliate LARCs, has continued the biofortification project. The primary
vehicle has been the HarvestPlus initiative, "a global alliance of research
institutions and implementing agencies coming together to breed and
disseminate crops with nutritive value (biofortification), e.g. with a higher
content of iron, zinc and vitamin A." 4 2
In terms of its governance framework, HarvestPlus is a partnership
between the Colombia- and U.S.-based International Center for Tropical
Agriculture (CIAT) and IFPRI; both are CGIAR's IARCs. HarvestPlus is
administered by a Project Advisory Committee (PAC) which is composed,
in part, by representatives of both CIAT and IFPRI.143 After its launch in
2004, HarvestPlus is on record as the first recipient of funding for
biofortification research granted by the Bill and Melinda Gates Foundation
(BMGF), an organization that is also proactive in a public goods approach
to global health crises, especially in less-developed countries. HarvestPlus
has since expanded its donor list, marking a strategic new phase in non-
profit interest in activities of CGIAR and in the advancement of public
goods approach to agricultural biotechnology. HarvestPlus prides itself "as
a global leader in developing biofortified crops and now works with more
than 200 agricultural and nutrition scientists around the world."l 4 4
Experts claim that "[t]he biofortification approach is backed by sound
science." 45 Investigations into the scientific integrity of biofortification
confirm that most staple crops have substantial and useful genetic traits and
variations that are stable across a range of growing environments. They
also affirm that breeding programs can easily manage nutritional quality
traits in many staple crops while traits for qualitative nutrition can be fused
with greater agronomic traits capable of enhancing yields. 146
HarvestPlus's initial efforts at biofortification focus on six select
staple crops over which pre-breeding studies have been completed. They
are beans, cassava, sweet potatoes, rice, maize and wheat. Although these
crops are low in micronutrients, they are subject to high consumption in
less-developed countries. Combining conventional and novel breeding
techniques, as well as molecular biological insights, biofortification is a
quasi-biotechnological intervention program aimed at inducing or boosting
micronutrient-enhancing traits in the target crop for improved nutritional
outcomes. In essence, it is a nutraceutional or functional food initiative.
142. Sasson, supra note 18, at 14.
143. Breeding Crops for Better Nutrition, HARVESTPLUS, http://www.harvestplus.
org/content/governance (last visited Mar. 4, 2012).
144. About HarvestPlus, HARVESTPLUS, http://www.harvestplus.org/content/about-
harvestplus (last visited Mar. 4, 2012).
145. Sasson, supra note 18, at 14.
146. Id.
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Since 2005, these crops have remained active targets of different aspects of
biofortification R&D that seeks to extend nutritional benefits to vulnerable
and malnourished populations in less-developed countries. Cumulatively,
these crops are critical sources of staple food for significant population
groups in Mexico, for example, and most less-developed countries of Asia,
Africa and South America.
HarvestPlus's phased program of work has a far-reaching, ambitious
scope. Its stated aims are to: 1) determine nutritionally optimal breeding
objectives; 2) screen CGIAR germplasm for high iron, zinc and beta-
carotene amounts; 3) examine the effects of food processing on
micronutrient content and bioavailability; 4) identify the [genetic] markers
available to facilitate the transfer of traits through conventional breeding;
5) undertake in vitro and animal studies to determine the bioavailability of
the enhanced micronutrients in promising lines; and 6) begin bio-efficiency
studies to determine effect on biofortified crops on micro-nutrient
status." 147
C. Biofortification: Drawbacks and Benefits
As already noted, most of the criticisms associated with the uptake of
agricultural biotechnology, food aid and agricultural assistance, especially
by less-developed countries, are tenable in regard to biofortified food
products. For example, Altieri argues that:
People do not exhibit vitamin A deficiency because rice
contains little vitamin A, or beta-carotene, but rather
because [instead of a more varied diet] their diet has been
reduced to rice and almost nothing else . . . A magic-bullet
solution, which places beta-carotene into rice while
leaving poverty, poor diets, and extensive monoculture
intact, is unlikely to make any durable contribution to
well-being.14 8
Similarly, Labonte et al. point out that countries of the G8 undermine
food security and nutritional welfare of less-developed countries, especially
in sub-Sahara Africa.149 They point to the hypocrisy of EU countries that
limit fishing vessels within their waters to protect stock and simultaneously
engage in paying generous compensation for European fishers affected by
147. HARVEST PLUS, HARNESSING AGRICULTURAL BIOTECHNOLOGY TO IMPROVE THE
HEALTH OF THE POOR: PLANT BREEDING TO COMBAT MICRONUTRIENT DEFICIENCY, 3
(2003), available at http://www.zab.uni-freiburg.de/forschung/HarvestPlusBrochure.
pdf
148. Altieri, supra note 38.
149. See LABONTE ET AL., supra note 82, at 93.
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the depletion of stock and tightened restrictions on fishing.150 Contrary to
G8 and EU posturing on food security in less-developed countries, they
pressure those less-developed countries to grant unsustainable fishing
licenses. 1s Through those licenses, European vessels engage in factory-
style over-fishing activities, which result in the depletion of fish stocks and
a threat to the nutritional balance and health of coastal communities,
especially in Africa.152
Despite these and several other drawbacks, as an initiative with
significant public health benefits, the biofortification program has more to
commend than to condemn it. Clearly, it is one of several concurrent and
multi-pronged approaches to tackling nutritional crises in less-developed
countries. It is hardly a magic bullet for everything wrong with the global-
political economics of food and agriculture. Given the backdrop of
malnutrition-driven public health crises in less-developed countries,
biofortification becomes a compelling option, at least in terms of its
empirical and timely results that match the urgency posed by these crises.
Other mutually reinforcing mechanisms with biofortification for addressing
the nutritional crisis as a public health intervention strategy include
continuing nutritional education, especially targeting parents and children
as the 2006 World Bank Studies on nutrition indicate.153 Indeed, dietary
uptake of micronutrient-rich vegetables, fruits, animal and fish products
remains an important aspect of improving the nutritional profile in less-
developed countries that needs to be promoted as matter of lifestyle, akin to
physical exercise in the containment of the obesity epidemic.
A few features of the biofortification initiative under the CGIAR extol
it in relation to the general skepticism around agricultural biotechnology.
First, it is being implemented by the CGIAR/IFPRI within a pubic goods
approach to the extension of the benefits of agricultural innovation to the
poor. Second, so far, CGIAR has co-opted the private sector in the
elaboration of this public goods vision. Even though the outcome of this
experience remains inchoate, it assists in fostering practical understanding
of public-private partnership in the context of food and agriculture as a
global public good. Third, unlike the GMOs and other products of
biotechnology, thus far, the HarvestPlus biofortification project targets key
staple crops that are selected not necessarily on the basis of their market
relevance. Rather, the crops are attractive because of their endemic or
integral profile to the food culture of the target population. Fourth, the
150. Id.
151. Id.
152. See Labonte, supra note 82 (Focusing on the Mauritanian experience, they argue
that G8 practices contribute directly to the problems of facing Africa's human and
economic development. One such practice, involves factory fishing off Africa's coast.).
153. See supra note 101 and accompanying text.
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operational modality of the HavestPlus initiative aims at boosting self-
reliance and knowledge transfer for members of indigenous and local
communities. This is in contrast to the tendency of the biotechnology
industrial complex to lock up knowledge by a combination of intellectual
property and technology control mechanisms and to encourage dependence
and reliance on external interests by these communities. The HarvestPlus
model is a potential scheme to adapt modern biotechnology "to the
marginal environments where resource-poor farmers live."' 5 4 Fifth, the
emphasis of biofortification program on key staple foods may not align
with traditional diversity of agricultural crops in the target population.
However, since biofortification under the HarvestPlus program
involves publicly held germplasms in the IARCs' ex situ gene banks, many
of which are located in less-developed countries, the program takes the
form of agricultural assistance rather than food aid. It exposes members of
indigenous and local communities to dynamic new ways of dealing with
their traditional landraces. Further, the broad outreach of the initiative and
diverse collaborations undergirding its implementation create ample
knowledge transfer and knowledge convergence opportunities. The ability
to extend biofortification to traditional landraces of indigenous and local
communities is perhaps one way of developing biotechnology locally under
a culturally sensitive, purposeful and pragmatic arrangement.
The interest of the BMGF and a few other not-for-profit organizations
in the biofortification and functional food program is instructive and
symbolic in several respects. First, it identifies in a positive way the link
between agricultural biotechnology and public health, especially in less-
developed countries. The BMGF is already a significant player in
addressing the lapses in pharmaceutical R&D and in plugging the access
gap to essential drugs for needy population. As already noted, the access
freeze to essential drugs for needy populations is an aspect of the global
public health crisis that is now tackled both by a combination of therapeutic
and preventive strategies. The biofortification project is mainly a
preventive public health strategy.
Increased interest of public, private and non-profit entities in the
HarvestPlus biofortification project will raise similar issues in regard to
intellectual property and proprietary control of research and innovation.
The CGIAR, its IARCs and the HarvestPlus program focus on germplasms
from publicly held gene banks. That does not necessarily settle the
intellectual property question, especially given the diversity of interest of
the multifarious collaborating institutions. Also, the biofortification
program provides a platform R&D opportunity, with capacity for
expansion to other crops and markets beyond less-developed countries.
154. Altieri, supra note 38; see also supra note 126 and accompanying text.
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That potential for expansion of the biofortification to program to developed
countries outside the public goods parameter will raise strong intellectual
property and market opportunities that stakeholders in the program will be
inclined to exploit.
As in the pharmaceutical R&D sector, a major challenge for all
stakeholders in the biofortification project is to develop a business model or
proprietary control strategy, including intellectual property that advances
their objectives. Presently, insofar as malnutrition in less-developed
countries accounts for a significant part of the global burden of disease, and
consequently a public health crisis, biofortification represents a viable
option for mitigating the crisis. As such, the global public goods argument
is equally applicable and provides an appropriate basis for leveraging
intellectual property or proprietary constraints in order to realize the full
benefits of this form of biotechnology intervention to public health.
V. CONCLusIoN
Like most paradigmatic technologies, biotechnology, especially in the
context of agriculture, is a subject of controversy in some quarters. While
proponents and opponents of agricultural biotechnology are locked in deep
disagreement over the veracity of various claims made in regard to the
overall contributions of agricultural biotechnology, this has not slowed the
rapid pace of global uptake of agricultural technology as the source of
twenty-first century global food supply. Against the backdrop of historical
transformation in agricultural production, genetic engineering-driven
agricultural biotechnology marks a remarkable shift in the scientific
template of agricultural innovation. Such a change has opened modem
agriculture to greater opportunities that are often clouded by the ideological
and passionate oppositions to agricultural biotechnology as well as such
oppositions that arise from the global-political economics of agriculture,
especially in regard to food security.
However, a more pragmatic and prudent approach to the promise and
potentials of agricultural biotechnology easily demonstrates the benefits of
this form of innovation in other areas of need, particularly in regard to
malnutrition as a critical aspect of global public health crises, especially in
less-developed countries. It is possible that given the urgency and the crisis
undertone of malnutrition, a strategic deployment of agricultural
biotechnology in a constructive manner that adapts insights thereof to local
and cultural sensitivities of target populations and associated agricultural
practices could mitigate, if not help re-appraise, the characteristic
suspicions over agricultural biotechnology. Like all paradigmatic
innovations, the challenge of agricultural biotechnology lies in negotiating
its access for those in need and in balancing its pros and cons and its
sustainability for ultimate public good. The choice is not between
2011] 295
296 JOURNAL OF FOOD LAW & POLICY [VOL.7
changing the food supply and changing consumer habits to meet health
needs. We need to do both. Agricultural biotechnology spurs important
evolutions within the food industry and opens opportunities, alongside
other forms of agricultural practices for a targeted revolution in nutritional
awareness and education with potential to positively impact nutrition-
related global public health crises, especially in the less-developed world.
